Variant report
Variant | nsv517418 |
---|---|
Chromosome Location | chr11:25616540-25625889 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:25619794..25621822-chr11:25698109..25699950,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16914165 | chr11:25616540-25616541 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs574982749 | chr11:25616581-25616582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568728704 | chr11:25616583-25616584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563307376 | chr11:25616626-25616627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs74763394 | chr11:25616631-25616632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529510948 | chr11:25616645-25616646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545913035 | chr11:25616658-25616659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184373968 | chr11:25616682-25616683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs36121785 | chr11:25616689-25616690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528625168 | chr11:25616723-25616724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547169122 | chr11:25616727-25616728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536613068 | chr11:25616794-25616795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568683103 | chr11:25616834-25616835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547954714 | chr11:25616846-25616847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529579060 | chr11:25616862-25616863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs189260729 | chr11:25616872-25616873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76700377 | chr11:25616879-25616880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73431369 | chr11:25616912-25616913 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs377054166 | chr11:25616923-25616924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554116973 | chr11:25616970-25616971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551923908 | chr11:25616972-25616973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112327095 | chr11:25616973-25616974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10742102 | chr11:25616975-25616976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370254546 | chr11:25616976-25616977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs71447426 | chr11:25616979-25616980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs367810181 | chr11:25616980-25616981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs202200698 | chr11:25616982-25616983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142982612 | chr11:25617015-25617016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552708522 | chr11:25617026-25617027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs72872905 | chr11:25617101-25617102 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs556229486 | chr11:25617105-25617106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535336702 | chr11:25617150-25617151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs556823280 | chr11:25617171-25617172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574655912 | chr11:25617217-25617218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546175788 | chr11:25617220-25617221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564326993 | chr11:25617221-25617222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535326187 | chr11:25617247-25617248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs143724363 | chr11:25617250-25617251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187654203 | chr11:25617277-25617278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs148112490 | chr11:25617301-25617302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529491331 | chr11:25617339-25617340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190837699 | chr11:25617357-25617358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563185744 | chr11:25617369-25617370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533499206 | chr11:25617370-25617371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs376175535 | chr11:25617391-25617392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs141282614 | chr11:25617400-25617401 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570361768 | chr11:25617427-25617428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534379770 | chr11:25617455-25617456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs113342664 | chr11:25617483-25617484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371645360 | chr11:25617486-25617487 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:25615800-25617400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr11:25616000-25619400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr11:25617400-25620200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr11:25619200-25619600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr11:25619400-25619800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr11:25619400-25619800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr11:25619600-25623400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
8 | chr11:25619800-25623400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr11:25620200-25623800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
10 | chr11:25623000-25623200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr11:25623400-25624400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr11:25623400-25624400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
13 | chr11:25623400-25624400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr11:25623400-25624600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr11:25623800-25624000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr11:25623800-25624000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
17 | chr11:25624000-25624400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
18 | chr11:25624400-25624800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |